Straits Times Index
3,227.10 -35.97 (-1.10%) Nikkei
27,153.83 -159.30 (-0.58%) Hang Seng
17,933.27 -214.68 (-1.18%) FTSE 100
7,018.60 -140.92 (-1.97%) BTC-USD
19,087.81 +20.41 (+0.11%) CMC Crypto 200
434.61 -9.92 (-2.23%)
Viatris Inc. (VTRS)
After hours:
- Zacks
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Merck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to Januvia/Janumet against Viatris, which is looking to market its generic versions of the medicines in the United States
- Motley Fool
Is Viatris Stock a Buy Now?
Pharmaceutical businesses spend billions of dollars developing medicines that they then protect with a fortress of intellectual property (IP) safeguards to make sure that competitors can't benefit from their work. But if you're not looking for dividend payments, it's hard to see how it would outperform the market, since it isn't engaged in a high-growth niche, nor is it planning to make significant innovations that would give it an edge over the competition.
- Motley Fool
Want Passive Income? Buy These 2 Beaten-Down Dividend Stocks
If you want to secure a decent yield, it can pay to buy shares of strong companies dealing with short-term problems.
